(Q34699281)

4 August 2017

1 reference

title

Cardioselective beta-blockers for chronic obstructive pulmonary disease. (English)

1 reference

chronic obstructive pulmonary disease

4 August 2017

main subject

1 reference

based on heuristic

inferred from title

author

Edwin Ernest Salpeter

series ordinal

3

object named as

E Salpeter

1 reference

4 August 2017

4

P Poole

1 reference

4 August 2017

S S Salpeter

1

1 reference

4 August 2017

T Ormiston

series ordinal

2

1 reference

4 August 2017

C Cates

series ordinal

5

1 reference

4 August 2017

publication date

1 January 2002

1 reference

Cochrane Database of Systematic Reviews

4 August 2017

published in

1 reference

4 August 2017

issue

2

1 reference

4 August 2017

page(s)

CD003566

1 reference

Labetalol, beta blockers, and acute deterioration of chronic airway obstruction.

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Ventilatory effects of long-term treatment with pindolol and metoprolol in hypertensive patients with chronic obstructive lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Comparative effects of bisoprolol and acebutolol in smokers with airway obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

The effects of oral propranolol and metoprolol on lung function and exercise performance in chronic airways obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Comparison of atenolol and oxprenolol in patients with angina or hypertension and co-existent chronic airways obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Comparison of effects of propranolol and metoprolol on airways obstruction in chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Reversibility of bronchospasm in airway obstruction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Dose-response relationship of the ?-adrenoceptor antagonist bisoprolol in patients with coronary heart disease and chronic obstructive bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Bopindolol, pindolol, and atenolol in patients with chronic obstructive lung disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Effect of propranolol on respiratory function and exercise tolerance in patients with chronic obstructive lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Propranolol and pindolol in chronic obstructive lung disease (author's transl)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Quality of life in treatment of hypertension. A metaanalysis of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Beta-blockers and depression. Evidence against an association

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Beta-blockers after myocardial infarction: do benefits ever outweigh risks in asthma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Effectiveness of beta-blocker therapy after acute myocardial infarction in elderly patients with chronic obstructive pulmonary disease or asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

21 January 2018

Beta-blockers and asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Effects of beta-blocker therapy on mortality in patients with heart failure. A systematic overview of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

The applied pharmacology of beta-adrenoceptor antagonists (beta blockers) in relation to clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

The effect of metoprolol and practolol on lung function and blood pressure in hypertensive asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

beta Blockade after myocardial infarction: systematic review and meta regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Changes in rates of beta-blocker use between 1994 and 1997 among elderly survivors of acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Pooling research results: benefits and limitations of meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Clinical relevance of pharmacokinetic differences between beta blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Diabetic patients and beta-blockers after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Treatment of hyperthyroid disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

β-Adrenergic Blockade for Survivors of Acute Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Early beta-blocker therapy for acute myocardial infarction in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Newer beta blockers and the treatment of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

-Adrenergic blockade with practolol in acetylcholine-sensitive asthma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Choice of drug treatment for elderly hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Required beta blocker profile in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Beta blocker use in the treatment of community hospital patients discharged after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Comparison of intravenous AH 5158 (ibidomide) and propranolol in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

A comparison of electrophysiologically guided antiarrhythmic drug therapy with beta-blocker therapy in patients with symptomatic, sustained ventricular tachyarrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Atenolol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Reduction of exercise tachycardia in man after propranolol, atenolol and bisoprolol in comparison to beta-adrenoceptor occupancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Beta blockade during and after myocardial infarction: an overview of the randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Effects of Labetalol in Hypertensive Patients with Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Meta-analysis of Trials Comparing β-Blockers, Calcium Antagonists, and Nitrates for Stable Angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

A comparison of oral metoprolol and propranolol in patients with chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

A comparison of celiprolol and chlorthalidone in hypertensive patients with reversible bronchial obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Effects of single oral doses of bisoprolol and atenolol on airway function in nonasthmatic chronic obstructive lung disease and angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Effect of metoprolol on cardiac and pulmonary function in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Comparative effects of celiprolol, propranolol, oxprenolol, and atenolol on respiratory function in hypertensive patients with chronic obstructive lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Beta1-blocker (practolol) and exercise in patients with chronic obstructive lung disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Beta-adrenoceptor blockers and terbutaline in patients with chronic obstructive lung disease. Effects and interaction after oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Effect of intravenous metoprolol on reversible obstructive airways disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Effects of oxprenolol on the airways of normal and bronchitic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Adverse effect of propranolol on airway function in nonasthmatic chronic obstructive lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Influence of cardioselectivity and respiratory disease on pulmonary responsiveness to beta-blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

[On the effect of adrenergic beta-receptor-blocking agents on the ventilatory function in obstructive lung diseases]

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Suppression of atrial ectopy with intravenous metoprolol in chronic obstructive pulmonary disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

[Effect of various beta-receptor blockaders on ventilation in patients with obstructive respiratory tract disease. Comparative studies]

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

A comparison of statistical methods for combining event rates from clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Cardiovascular risk and risk factors in a randomized trial of treatment based on the beta-blocker oxprenolol: the International Prospective Primary Prevention Study in Hypertension (IPPPSH). The IPPPSH Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Usefulness of beta-blocker therapy in patients with non-insulin-dependent diabetes mellitus and coronary artery disease. Bezafibrate Infarction Prevention (BIP) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

The effect of oxprenolol, acebutolol and propranolol on thyroid hormones in hyperthyroid subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Physician use of beta-adrenergic blocking therapy: a changing perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Treatment of hypertension in mild asthmatic patients with atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Pafenolol, a highly selective β1-adrenoceptor–antagonist, in asthmatic patients: Interaction with terbutaline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

EFFECT OF A β-ADRENERGIC-BLOCKING AGENT, PROPRANOLOL, ON ASTHMATICS

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Safety of esmolol in patients with acute myocardial infarction treated with thrombolytic therapy who had relative contraindications to beta-blocker therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Effect of a selectivebeta-adrenergic blocker in preventing falls in arterial oxygen tension following isoprenaline in asthmatic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Near-fatal bronchospasm after oral nadolol in a young asthmatic and response to ventilation with halothane.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Beta adrenoceptor antagonists and respiratory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Respiratory function in the elderly and the effects of beta blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Beta blockers prevent cardiac death following a myocardial infarction: so why are so many infarct survivors discharged without beta blockers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

National patterns and predictors of beta-blocker use in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

Bronchial response to beta-adrenergic blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566

10.1002/14651858.CD003566

21 January 2018

Identifiers

DOI

1 reference

4 August 2017

1 reference